Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
Top Cited Papers
- 12 July 2012
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 367 (2), 124-134
- https://doi.org/10.1056/nejmoa1204242
Abstract
Hydroxyethyl starch (HES) is widely used for fluid resuscitation in intensive care units (ICUs), but its safety and efficacy have not been established in patients with severe sepsis.Keywords
This publication has 28 references indexed in Scilit:
- Consensus statement of the ESICM task force on colloid volume therapy in critically ill patientsIntensive Care Medicine, 2012
- A Systematic Review of Third-Generation Hydroxyethyl Starch (HES 130/0.4) in ResuscitationAnesthesia & Analgesia, 2011
- Initial fluid resuscitation of patients with septic shock in the intensive care unitActa Anaesthesiologica Scandinavica, 2011
- Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trialTrials, 2011
- Are small hospitals with small intensive care units able to treat patients with severe sepsis?Intensive Care Medicine, 2010
- Preferences for colloid use in Scandinavian intensive care unitsActa Anaesthesiologica Scandinavica, 2008
- Intensive Insulin Therapy and Pentastarch Resuscitation in Severe SepsisNew England Journal of Medicine, 2008
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Effects of hydroxyethyl starch administration on renal function in critically ill patientsBritish Journal of Anaesthesia, 2007
- Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised studyThe Lancet, 2001